CYP27A1 Gene Cerebrotendinous Xanthomatosis NGS Genetic Test
Short Name: CYP27A1 CTX NGS
Also known as: CYP27A1 Gene Sequencing, Sterol 27-Hydroxylase Gene Test, CTX Genetic Test, Cerebrotendinous Xanthomatosis NGS Panel
CYP27A1 Gene Cerebrotendinous Xanthomatosis NGS Genetic Test test available at DNA Labs India for ₹20,000. Uses Next-Generation Sequencing (NGS), Sanger Sequencing for variant confirmation on Blood or Extracted DNA or One drop Blood on FTA Card samples. Results in Reports are generally issued within 3-4 weeks from the date of sample receipt. In some cases, additional confirmation testing (e.g., Sanger) may extend the turnaround time by a few days.. Free home collection in 300+ cities across India.
🩺 Medically Reviewed By
Dr SULOCHANA HEMCHANDRA HOLLA
Consultant Medical Geneticist · Reg: 8532
Last updated: September 7, 2026
Overview
The purpose of this test is to detect pathogenic variants in the CYP27A1 gene, confirming the diagnosis of cerebrotendinous xanthomatosis (CTX) in symptomatic patients and enabling carrier testing, presymptomatic diagnosis, and informed genetic counselling for at-risk families. NGS genetic DNA test detecets for variant and mutation detection in CYP27A1 gene for Cerebrotendinous xanthomatosis
- Test Code
- 3949
- Price
- ₹20,000
- Sample Type
- Blood or Extracted DNA or One drop Blood on FTA Card
- Result Time
- Reports are generally issued within 3-4 weeks from the date of sample receipt. In some cases, additional confirmation testing (e.g., Sanger) may extend the turnaround time by a few days.
- Fasting Required
- No
- Method
- Next-Generation Sequencing (NGS), Sanger Sequencing for variant confirmation
Cerebrotendinous xanthomatosis (CTX) is an autosomal recessive disorder caused by mutations in the CYP27A1 gene. The CYP27A1 gene encodes a mitochondrial enzyme called sterol 27-hydroxylase, which plays a crucial role in the conversion of cholesterol to bile acids. CTX is characterized by the accumulation of cholestanol and cholesterol in various tissues, including the brain, tendons, and lenses of the eyes.
Symptoms of CTX
CTX is a progressive disorder that usually presents in early adulthood. The symptoms of CTX can vary widely but typically include:
- Chronic diarrhea
- Cognitive impairment
- Developmental delay
- Seizures
- Spasticity
- Visual impairment
- Tendon xanthomas (yellowish deposits of cholesterol in tendons)
Diagnosis of CTX
CTX is diagnosed based on clinical symptoms, biochemical tests, and genetic testing. The diagnosis of CTX is confirmed by the presence of elevated levels of cholestanol in the blood and/or urine. Genetic testing can identify mutations in the CYP27A1 gene, which confirm the diagnosis of CTX.
NGS Genetic DNA Test
The Next-Generation Sequencing (NGS) Genetic DNA Test is a powerful tool for the diagnosis of CTX. This test uses high-throughput sequencing technology to analyze the entire CYP27A1 gene, including all exons and introns. The NGS Genetic DNA Test can identify all known mutations in the CYP27A1 gene, allowing for accurate and comprehensive diagnosis of CTX.
Cost of NGS Genetic DNA Test
The cost of the NGS Genetic DNA Test for CTX is INR 20,000. This includes the cost of sample collection, DNA extraction, sequencing, and analysis. The NGS Genetic DNA Test is available at DNA Labs India, a leading provider of genetic testing services in India.
Conclusion
CTX is a rare genetic disorder that can have serious consequences if left untreated. The NGS Genetic DNA Test is a powerful tool for the accurate diagnosis of CTX. If you or someone you know is experiencing symptoms of CTX, it is important to seek medical attention and consider genetic testing. At DNA Labs India, we are committed to providing accurate and affordable genetic testing services to individuals and families affected by genetic disorders.
Contact us today to learn more about our NGS Genetic DNA Test for CTX and other genetic testing services.
Cerebrotendinous xanthomatosis (CTX) is a rare genetic disorder characterized by the accumulation of cholesterol and cholestanol in various tissues, including the brain, tendons, and other body parts. It is caused by mutations in the CYP27A1 gene.
The CYP27A1 gene encodes an enzyme called sterol 27-hydroxylase, which plays a crucial role in the breakdown of cholesterol and the synthesis of bile acids. Mutations in the CYP27A1 gene lead to reduced or absent activity of this enzyme, resulting in the accumulation of cholesterol precursors in the body.
CTX is associated with a range of symptoms, including neurological problems such as cognitive impairment, ataxia (loss of coordination), seizures, and psychiatric symptoms. Tendon xanthomas, which are fatty deposits in the tendons, are also a characteristic feature of the disorder.
Next-Generation Sequencing (NGS) is a genetic testing technique that can be used to identify mutations or variations in the CYP27A1 gene associated with cerebrotendinous xanthomatosis. NGS allows for the simultaneous analysis of multiple genes, providing comprehensive genetic information for accurate diagnosis.
If you suspect that you or someone you know might have cerebrotendinous xanthomatosis or any other genetic disorder, it's important to consult with a neurologist, medical geneticist, or healthcare professional with expertise in metabolic and neurological disorders. Genetic testing, along with clinical evaluation and specialized testing, can help confirm the diagnosis and guide appropriate management strategies.
As always, seeking accurate information and proper care from medical experts and reliable sources is essential.
Sample Collection
No special preparation or fasting is required. Please inform the lab if the patient has a history of recent blood transfusion, bone marrow transplantation, or haematological malignancy.
Method: Venipuncture or FTA card spot
Laboratory Analysis
A trained phlebotomist will collect a blood sample from a vein in your arm using a sterile needle. For FTA card collection, a few drops of blood are placed on the card and allowed to air dry.
Report Delivery
Resume normal activities immediately. Press the collection site to prevent bruising. For FTA card, ensure it is labelled and placed in the provided envelope.
Timeline: Reports are generally issued within 3-4 weeks from the date of sample receipt. In some cases, additional confirmation testing (e.g., Sanger) may extend the turnaround time by a few days.
Patient Instructions
About This Test
Who Should Get This Test
The purpose of this test is to detect pathogenic variants in the CYP27A1 gene, confirming the diagnosis of cerebrotendinous xanthomatosis (CTX) in symptomatic patients and enabling carrier testing, presymptomatic diagnosis, and informed genetic counselling for at-risk families.
NGS genetic DNA test detecets for variant and mutation detection in CYP27A1 gene for Cerebrotendinous xanthomatosis
How to Prepare
- Do not transfer the sample to another container without instructions.
- If using FTA card, let the blood spot dry completely for at least 1 hour before sealing.
- Label the sample tube/card with patient name, date of birth, and collection date.
- Maintain sample at room temperature if shipping within 24 hours; otherwise refrigerate.
Doctor's Notes
Reviewed by Dr SULOCHANA HEMCHANDRA HOLLA — MBBS, MD (Medical Genetics) · Reg. No. 8532
"Genetic testing for CTX is essential for early diagnosis and prenatal counselling. At DNA Labs India, the NGS-based approach ensures comprehensive and reliable results to guide clinical management and reproductive decisions."
Last updated: September 7, 2026
Test Parameters & Specifications
Sample Stability
- Improperly labelled sample
- Clotted or haemolyzed blood sample
- Sample leaked during transport
- FTA card with insufficient blood or contamination
- Frozen whole blood (causes lysis and DNA degradation)
Understanding Your Results
Negative (no pathogenic variant detected)
CYP27A1-associated CTX is unlikely, but biochemical testing and clinical correlation are still required.
Positive - homozygous or compound heterozygous pathogenic variants
Confirms molecular diagnosis of CTX; autosomal recessive pattern.
Carrier (single pathogenic variant)
Individual is an asymptomatic carrier; at-risk for CTX only if partner carries a variant in the same gene.
Variants of uncertain significance (VUS)
Additional family segregation studies and clinical-biochemical correlation are needed to reclassify the variant.
Consult a neurologist or medical geneticist if you or a family member experience unexplained chronic diarrhea, early-onset cataracts, tendon xanthomas, gait ataxia, spasticity, seizures, cognitive decline, or if there is a known family history of cerebrotendinous xanthomatosis.
Limitations
- ⚠NGS may not reliably detect large structural rearrangements, deep intronic variants, or repeat expansions; additional testing may be required.
- ⚠Variants of uncertain significance (VUS) may be reported; further family studies and functional analysis are often necessary.
- ⚠This test does not assess biochemical markers like cholestanol levels; correlation with clinical and biochemical findings is essential.
- ⚠Rare genetic variants in other genes with overlapping phenotypes may not be covered by this single-gene test.
Risks & Considerations
- ●Minimal risk of bruising or infection at the blood collection site.
- ●Psychological impact of learning a genetic diagnosis (positive or carrier).
- ●Possibility of finding variants of uncertain significance.
- ●Implications for family members that may require further testing.
Interfering Factors
- ●Maternal cell contamination in prenatal samples
- ●Unexpected clonal haematopoiesis in blood DNA
- ●Contamination with foreign DNA during sample handling
- ●Poor DNA quality due to hemolysis or improper storage
- ●Recent blood transfusion can dilute patient's own DNA
Compare With Similar Tests
| Test | CYP27A1 Gene Cerebrotendinous Xanthomatosis NGS Genetic Test | |||
|---|---|---|---|---|
| Comparison | CYP27A1 Gene Cerebrotendinous Xanthomatosis NGS Genetic Test |
Frequently Asked Questions
What is Cerebrotendinous Xanthomatosis (CTX)?
Why is the CYP27A1 gene NGS genetic test done?
What is the cost of this test?
What sample is required for this test?
Do I need to fast before the test?
How long does it take to get the report?
What does a positive test result mean?
Can this test be done during pregnancy?
Is genetic counselling recommended before the test?
Does insurance cover the cost of this test?
How accurate is the NGS technology used in this test?
Can this test be used for family screening?
Related Tests
Reference Laboratory Services
We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.
Your Data Privacy
Your medical data is protected under Indian law.
✓ Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.
✓ DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.
Book Your Test
Enter your details and we'll connect you within 15 minutes.